CardioComm Solutions Inc. (EKG) - Net Assets
Based on the latest financial reports, CardioComm Solutions Inc. (EKG) has net assets worth CA$-567.74K CAD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$256.24K) and total liabilities (CA$823.97K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-567.74K |
| % of Total Assets | -221.57% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CardioComm Solutions Inc. - Net Assets Trend (2013–2024)
This chart illustrates how CardioComm Solutions Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CardioComm Solutions Inc. (2013–2024)
The table below shows the annual net assets of CardioComm Solutions Inc. from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CA$-276.58K | +45.19% |
| 2023-12-31 | CA$-504.65K | -23.89% |
| 2022-12-31 | CA$-407.32K | +3.79% |
| 2021-12-31 | CA$-423.38K | +36.84% |
| 2020-12-31 | CA$-670.32K | +25.17% |
| 2019-12-31 | CA$-895.81K | -1209.41% |
| 2018-12-31 | CA$-68.41K | -113.98% |
| 2017-12-31 | CA$489.32K | +6421.10% |
| 2016-12-31 | CA$-7.74K | +98.87% |
| 2015-12-31 | CA$-687.89K | -15.45% |
| 2014-12-31 | CA$-595.83K | -75.53% |
| 2013-12-31 | CA$-339.45K | -- |
Equity Component Analysis
This analysis shows how different components contribute to CardioComm Solutions Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 353494600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$35.17 Million | % |
| Total Equity | CA$-276.58K | 100.00% |
CardioComm Solutions Inc. Competitors by Market Cap
The table below lists competitors of CardioComm Solutions Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FDM Group Holdings PLC
LSE:FDM
|
$1.43 Million |
|
Rajdarshan Industries Limited
NSE:ARENTERP
|
$1.43 Million |
|
Avidian Gold Corp
V:AVG
|
$1.43 Million |
|
Cho Thavee Public Company Limited
BK:CHO
|
$1.43 Million |
|
Scheerders van Kerchove's Verenigde fabrieken nv
BR:SCHD
|
$1.43 Million |
|
22nd Century Group Inc
NASDAQ:XXII
|
$1.43 Million |
|
Lyra Therapeutics Inc
NASDAQ:LYRA
|
$1.43 Million |
|
Centenario Gold Corp.
V:CTG
|
$1.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CardioComm Solutions Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -504,650 to -276,578, a change of 228,072.
- Net loss of 194,576 reduced equity.
- Other factors increased equity by 422,648.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-194.58K | -70.35% |
| Other Changes | CA$422.65K | +152.81% |
| Total Change | CA$- | % |
Book Value vs Market Value Analysis
This analysis compares CardioComm Solutions Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CA$0.00 | CA$0.01 | x |
| 2018-12-31 | CA$0.00 | CA$0.01 | x |
| 2019-12-31 | CA$-0.01 | CA$0.01 | x |
| 2020-12-31 | CA$0.00 | CA$0.01 | x |
| 2021-12-31 | CA$0.00 | CA$0.01 | x |
| 2022-12-31 | CA$0.00 | CA$0.01 | x |
| 2023-12-31 | CA$0.00 | CA$0.01 | x |
| 2024-12-31 | CA$0.00 | CA$0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CardioComm Solutions Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -36.94%
- • Asset Turnover: 2.41x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.67%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | -100.45% | 1.73x | 0.00x | CA$-1.67 Million |
| 2014 | 0.00% | -63.45% | 1.44x | 0.00x | CA$-895.32K |
| 2015 | 0.00% | -34.76% | 1.65x | 0.00x | CA$-530.96K |
| 2016 | 0.00% | -1.48% | 1.35x | 0.00x | CA$-22.28K |
| 2017 | 8.09% | 2.28% | 1.13x | 3.15x | CA$-9.32K |
| 2018 | 0.00% | -53.65% | 0.99x | 0.00x | CA$-570.22K |
| 2019 | 0.00% | -121.40% | 2.71x | 0.00x | CA$-972.53K |
| 2020 | 0.00% | -7.62% | 2.31x | 0.00x | CA$3.43K |
| 2021 | 0.00% | 0.04% | 1.40x | 0.00x | CA$42.62K |
| 2022 | 0.00% | -0.25% | 3.56x | 0.00x | CA$38.28K |
| 2023 | 0.00% | -11.11% | 2.56x | 0.00x | CA$-46.86K |
| 2024 | 0.00% | -36.94% | 2.41x | 0.00x | CA$-166.92K |
Industry Comparison
This section compares CardioComm Solutions Inc.'s net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,220,184
- Average return on equity (ROE) among peers: -35.86%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CardioComm Solutions Inc. (EKG) | CA$-567.74K | 0.00% | N/A | $1.43 Million |
| Diagnos Inc (ADK) | $-1.95 Million | 0.00% | 0.00x | $18.42 Million |
| NetraMark Holdings Inc. (AIAI) | $1.83 Million | -284.61% | 0.19x | $61.38 Million |
| Comprehensive Healthcare Systems Inc (CHS) | $316.65K | -33.71% | 0.02x | $12.07 Million |
| Carespan Health Inc (CSPN) | $-699.52K | 0.00% | 0.00x | $688.89K |
| Kovo Healthtech Corp (KOVO) | $-614.00K | 0.00% | 0.00x | $1.28 Million |
| Kneat.com Inc (KSI) | $14.80 Million | -4.46% | 0.02x | $295.86 Million |
| Newtopia Inc (NEWU) | $-1.84 Million | 0.00% | 0.00x | $626.69K |
| Hydreight Technologies Inc (NURS) | $-784.54K | 0.00% | 0.00x | $135.22 Million |
| NexgenRX Inc. (NXG) | $-83.93K | 0.00% | 0.00x | $20.06 Million |
About CardioComm Solutions Inc.
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat " Mobile ECG device, and HeartCheck SMAR… Read more